A. Bout

发表

Infection efficiency of type 5 adenoviral vectors in synovial tissue can be enhanced with a type 16 fiber.

P. Goossens, M. Havenga, E. Pieterman, 2001, Arthritis and rheumatism.

Improved Adenovirus Vectors for Infection of Cardiovascular Tissues

P. Quax, M. Havenga, A. Lemckert, 2001, Journal of Virology.

Odocoileus hemionus deer adenovirus is related to the members of Atadenovirus genus

A. Zakhartchouk, M. Havenga, A. Bout, 2002, Archives of Virology.

Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors.

C. Avezaat, C. Vecht, A. Bout, 1996, Human gene therapy.

IL-1/IL-3 gene therapy of non-small cell lung cancer (NSCLC) in rats using ‘cracked’ adenoproducer cells

A. Bout, D. Valerio, J. Noteboom, 1998, Gene Therapy.

Propagation of Adenoviral Vectors: Use of PER. C6 Cells

W. W. Nichols, D. Kaslow, R. Hill, 2002 .

Adenovirus-mediated interleukin 3 beta gene transfer by isolated limb perfusion inhibits growth of limb sarcoma in rats.

A. Eggermont, J. D. Wilt, J. D. de Wilt, 2001, Human gene therapy.

Intra-CSF administered recombinant adenovirus causes an immune response-mediated toxicity

A. Bout, C. Vecht, D. Valerio, 2000, Gene Therapy.

Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity

S. Kostense, P. Quax, M. Havenga, 2003, Journal of Virology.

The influence of synovial fluid on adenovirus-mediated gene transfer to the synovial tissue.

F. Breedveld, P. Goossens, M. Havenga, 2001, Arthritis and rheumatism.

Highly Efficient Transduction of Human Monocyte-Derived Dendritic Cells with Subgroup B Fiber-Modified Adenovirus Vectors Enhances Transgene-Encoded Antigen Presentation to Cytotoxic T Cells1

R. Offringa, C. Melief, M. Havenga, 2001, The Journal of Immunology.

Antigen Presentation to Cytotoxic T Cells Vectors Enhances Transgene-Encoded Subgroup B Fiber-Modified Adenovirus Monocyte-Derived Dendritic Cells with Highly Efficient Transduction of Human

M. Havenga, A. Lemckert, A. Bout, 2001 .

Prospects for human gene therapy

A. Bout, 1996, European Journal of Drug Metabolism and Pharmacokinetics.

Cloning, biological characterization and high-level expression of rat interleukin-3 using recombinant adenovirus: description of a new splicing variant.

A. Bout, D. Valerio, D. V. van Bekkum, 1998, Gene.

Distribution of recombinant adenovirus in the cerebrospinal fluid of nonhuman primates.

A. Bout, C. Vecht, D. Valerio, 1999, Human gene therapy.

Exploiting the Natural Diversity in Adenovirus Tropism for Therapy and Prevention of Disease

P. Quax, T. Logtenberg, M. Mehtali, 2002, Journal of Virology.

Prevention of Disease Adenovirus Tropism for Therapy and Exploiting the Natural Diversity in

P. Quax, T. Logtenberg, M. Havenga, 2001 .

Intracerebral injection of adenovirus harboring the HSVtk gene combined with ganciclovir administration: toxicity study in nonhuman primates

A. Bout, D. Valerio, J. Kros, 1998, Gene Therapy.

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

A. van der Eb, A. Bout, K. Hehir, 1998, Human gene therapy.

A single short stretch of homology between adenoviral vector and packaging cell line can give rise to cytopathic effect-inducing, helper-dependent E1-positive particles.

J. Files, A. Bout, R. Vogels, 2002, Human gene therapy.

High‐Level Expression of Recombinant IgG in the Human Cell Line PER.C6

T. Logtenberg, D. Opstelten, A. Bout, 2003, Biotechnology progress.

Functions, Biogenesis and Pathology of Peroxisomes in Man

E. Wiemer, R. Wanders, R. Benne, 1989 .

Feasibility of adenovirus-mediated nonsurgical synovectomy in collagen-induced arthritis-affected rhesus monkeys.

F. Breedveld, P. Kluin, P. Goossens, 1999, Human gene therapy.

Simultaneous detection of NOS-3 protein expression and nitric oxide production using a flow cytometer.

P. Quax, M. Havenga, A. Bout, 2001, Analytical biochemistry.

Chapter 6 Propagation of Adenoviral Vectors Use of PER. C6 Cells

S. M. Galloway, K. Brouwer, W. W. Nichols, 2002, Adenoviral Vectors for Gene Therapy.

Characterization of the gene encoding human peroxisomal 3-oxoacyl-CoA thiolase (ACAA). No large DNA rearrangement in a thiolase-deficient patient.

L. Blonden, R. Benne, A. Bout, 1991, Biochimica et biophysica acta.

Zonal distribution of peroxisomal 3-oxoacyl-CoA thiolase mRNA in liver from rats treated with di-(2-ethylhexyl)phthalate.

A. Moorman, P. D. de Boer, R. Benne, 1990, Biochimica et biophysica acta.

Nucleotide sequence of human peroxisomal 3-oxoacyl-CoA thiolase.

R. Benne, A. Bout, J. Tager, 1988, Nucleic acids research.

Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37.

P. Bosma, A. Duncan, P. Jansen, 1993, Cytogenetics and cell genetics.

Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.

C. Avezaat, M. Havenga, A. Bout, 2001, Cancer Research.

Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene

A. Bout, D. Valerio, J. Noteboom, 1997, Gene Therapy.

The effect of promoter strength in adenoviral vectors in hyperplastic synovium.

F. Breedveld, P. Kluin, P. Goossens, 2000, Clinical and Experimental Rheumatology.

Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies.

C. Avezaat, A. Bout, P. Hoogerbrugge, 1997, Neurosurgery.

Molecular cytogenetic characterization by combined COBRA-FISH and fiber-FISH: application to PER.C6 cells.

H. Tanke, J. Wiegant, A. Raap, 2004, BioTechniques.

Molecular cytogenetic characterization by combined COBRA-FISH and fiber-FISH : application to PER . C 6 ® cells

H. Tanke, J. Wiegant, A. Raap, 2022 .

Treatment of leptomeningeal metastases in a rat model using a recombinant adenovirus containing the HSV-tk gene.

C. Avezaat, A. Bout, C. Vecht, 1996, Journal of neurosurgery.

Lung gene therapy: in vivo adenovirus-mediated gene transfer to rhesus monkey airway epithelium.

M. Perricaudet, B. Scholte, A. Bout, 1994, Human gene therapy.

Aerosol-mediated delivery of recombinant adenovirus to the airways of nonhuman primates.

A. Bout, A. Pavirani, J. Imler, 1995, Human gene therapy.

In vivo adenovirus-mediated transfer of human CFTR cDNA to rhesus monkey airway epithelium: efficacy, toxicity and safety.

M. Perricaudet, A. Bout, A. Pavirani, 1994, Gene therapy.

Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses.

M. Mehtali, A. Bout, A. Pavirani, 1995, Human gene therapy.

Isolated Limb Perfusion for Local Gene Delivery: Efficient and Targeted Adenovirus-Mediated Gene Transfer Into Soft Tissue Sarcomas

A. Eggermont, J. D. de Wilt, A. Bout, 2000, Annals of surgery.

ICAM-1 induction in respiratory cells exposed to a replication-deficient recombinant adenovirus in vitro and in vivo

A. Bout, A. Pavirani, A. Tamanini, 1998, Gene Therapy.

PER.C6® Cells for the Manufacture of Biopharmaceutical Proteins

D. Opstelten, A. Bout, J. Côté, 2008 .

Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity

S. Kostense, P. Quax, M. Havenga, 2003, Journal of Virology.

Demarcation of a sequence involved in mediating catabolite repression of the gene for the 11 kDa subunit VIII of ubiquinol-cytochrome c oxidoreductase in Saccharomyces cerevisiae

L. Grivell, A. Bout, A. Maarse, 1988, Nucleic Acids Res..